Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 8Lymphoma, Non-Hodgkin 7Recurrence 4Neoplasms 3Lymphoma, Large-Cell, Anaplastic 3Hodgkin Disease 2Hematologic Neoplasms 2Hematologic Diseases 2Sarcoma, Synovial 1Sarcoma 1Rhabdoid Tumor 1Multiple Myeloma 1Mesothelioma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Carcinoma 1

Interventions

tazemetostat 2Pemetrexed 2Cisplatin 2ruxolitinib 1ribociclib 1belinostat 1avelumab 1abemaciclib 1Sirolimus 1Rifampin 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Midazolam 1Letrozole 1LY3023414 1Itraconazole 1Immunotherapy, Adoptive 1Immunotherapy 1Imatinib Mesylate 1Fulvestrant 1Fluorodeoxyglucose F18 1Drug Therapy 1Doxepin 1Biological Therapy 14-(3-fluoropropyl)glutamic acid 1(4S)-4-(3-(18F)fluoropropyl)-L-glutamate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma × Rifampin × Lymphoid × Clear all
NCT04537715 2025-02-19

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

Ipsen

Phase 1 Completed
42 enrolled 39 charts
LymphoidOther hematologic neoplasmOther solid neoplasmSarcomaThoracic

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Sarcoma, Synovial, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡